The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Completed

• Conditions: End-stage Renal Disease
• Interventions: Other: renal replacement therapy

• Registration Number: NCT01612182
• Lead Sponsor: Inje University

Brief Summary

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-03
• Study Completion: 2012-05
• Study First Submitted: 2012-05-29
• Status Verified: 2012-06
• Study First Submitted QC: 2012-06-04
• Last Update Submitted: 2012-06-04
• Study First Posted: 2012-06-05
• Last Update Posted: 2012-06-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1289

Inclusion Criteria

• The age of patient was between 18 yrs and 79 yrs.
• The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

Exclusion Criteria

• The level of serum albumin was below 2.0 or over 5.0
• The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
• The level of Body mass index was below 15 or over 30
• Pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
ESBL(+) Klebsiella pneumonia	renal replacement therapy	All the patient who's the culture result showed ESBL(+) Klebsiella pneumonia in any site during hospitalization
ESBL(-) Klebsiella pneumonia	renal replacement therapy	All the patient who's the culture result showed ESBL(-) Klebsiella pneumonia in any site during hospitalization

Primary Outcome Measures

Name	Time	Method
The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy	During hospitalization	The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Secondary Outcome Measures

Name	Time	Method
The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy	during hospitalization	The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Trial Locations

Locations (1)

Inje University Seoul Paik hospital Instituional Board Review; 🇰🇷 Seoul, Je dong 2ga, Jung gu, Korea, Republic of